Belite Bio Ownership & Insider Activity

Belite Bio (BLTE) institutional and insider ownership, recent insider transactions and ownership breakdown.

Institutional investors hold 1.6%. Over the past 90 days, insiders made 5 sales worth $32.1M.

Shares Outstanding

37.515M

Shares Float

19.964M

Institutional Shares Held

633.475K

Institutional % Held

1.6%

Ownership Breakdown

Net Insider Activity by Month

Purchases (90d)

Sales (90d)

$32.1M total

Net Activity

Net Selling

Net Value (90d)

-$32.1M

Belite Bio Insider Transactions (Last 6 Months)

Date	Insider	Title	Type	Shares	Price	Value
Oct 1, 2026	Hendrik Peter Scholl	CHIEF MEDICAL OFFICER	SELL	500.000	$165.32	$83K
Sep 4, 2026	Yu-Hsin Lin	CHIEF EXECUTIVE OFFICER	SELL	100.435K	$190.00	$19.1M
Sep 4, 2026	Hao-Yuan Chuang	CHIEF FINANCIAL OFFICER	SELL	67.395K	$189.98	$12.8M
Aug 12, 2026	Chuang Hao-Yuan	CHIEF FINANCIAL OFFICER	SELL	367.000	$180.35	$66K
Aug 12, 2026	Lin Yu-Hsin	CHIEF EXECUTIVE OFFICER	SELL	365.000	$180.35	$66K
Jun 18, 2026	Hendrik Peter Scholl	CHIEF MEDICAL OFFICER	SELL	10.000K	$145.24	$1.5M
Jun 16, 2026	Hendrik Peter Scholl	CHIEF MEDICAL OFFICER	SELL	10.000K	$140.57	$1.4M
May 7, 2026	Nathan L Mata	CHIEF SCIENTIFIC OFFICER	SELL	666.000	$153.21	$102K
May 6, 2026	Nathan L Mata	CHIEF SCIENTIFIC OFFICER	SELL	1.000K	$153.84	$154K
May 5, 2026	Nathan L Mata	CHIEF SCIENTIFIC OFFICER	SELL	1.000K	$155.50	$156K
May 4, 2026	Nathan L Mata	CHIEF SCIENTIFIC OFFICER	SELL	1.000K	$155.64	$156K
May 1, 2026	Nathan L Mata	CHIEF SCIENTIFIC OFFICER	SELL	1.000K	$155.78	$156K